Global Intravenous Immunoglobulin (IVIg) Market Growth 2021-2026

  • receipt Report ID : 240252
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 161
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Intravenous Immunoglobulin (IVIg) will have significant change from previous year. By the most conservative estimates of global Intravenous Immunoglobulin (IVIg) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9523.6 million in 2020. Over the next five years the Intravenous Immunoglobulin (IVIg) market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 12080 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

IVIg Liquid

IVIg Powder

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Immunodeficiency

Autoimmune Disease

Acute Infection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption 2016-2026

2.1.2 Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region

2.2 Intravenous Immunoglobulin (IVIg) Segment by Type

2.2.1 IVIg Liquid

2.2.2 IVIg Powder

2.3 Intravenous Immunoglobulin (IVIg) Sales by Type

2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2016-2021)

2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2016-2021)

2.4 Intravenous Immunoglobulin (IVIg) Segment by Application

2.4.1 Immunodeficiency

2.4.2 Autoimmune Disease

2.4.3 Acute Infection

2.5 Intravenous Immunoglobulin (IVIg) Sales by Application

2.5.1 Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2016-2021)

2.5.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2016-2021)

2.5.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2016-2021)

3 Global Intravenous Immunoglobulin (IVIg) by Company

3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company

3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Company (2019-2021)

3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2019-2021)

3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company

3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2019-2021)

3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2019-2021)

3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company

3.4 Global Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Location Distribution

3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Intravenous Immunoglobulin (IVIg) by Region

4.1 Global Intravenous Immunoglobulin (IVIg) by Region

4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region

4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region

4.2 Americas Intravenous Immunoglobulin (IVIg) Sales Growth

4.3 APAC Intravenous Immunoglobulin (IVIg) Sales Growth

4.4 Europe Intravenous Immunoglobulin (IVIg) Sales Growth

4.5 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Growth

5 Americas

5.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country

5.1.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)

5.1.2 Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)

5.2 Americas Intravenous Immunoglobulin (IVIg) Sales by Type

5.3 Americas Intravenous Immunoglobulin (IVIg) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region

6.1.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021)

6.1.2 APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021)

6.2 APAC Intravenous Immunoglobulin (IVIg) Sales by Type

6.3 APAC Intravenous Immunoglobulin (IVIg) Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Intravenous Immunoglobulin (IVIg) by Country

7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)

7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)

7.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type

7.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Country

8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)

8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)

8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type

8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Intravenous Immunoglobulin (IVIg) Distributors

10.3 Intravenous Immunoglobulin (IVIg) Customer

11 Global Intravenous Immunoglobulin (IVIg) Market Forecast

11.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Region

11.1.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions (2021-2026)

11.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Intravenous Immunoglobulin (IVIg) Forecast by Type

11.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Application

12 Key Players Analysis

12.1 Baxter

12.1.1 Baxter Company Information

12.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Offered

12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Baxter Main Business Overview

12.1.5 Baxter Latest Developments

12.2 Grifols

12.2.1 Grifols Company Information

12.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Offered

12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Grifols Main Business Overview

12.2.5 Grifols Latest Developments

12.3 CSL

12.3.1 CSL Company Information

12.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Offered

12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 CSL Main Business Overview

12.3.5 CSL Latest Developments

12.4 Octapharma

12.4.1 Octapharma Company Information

12.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Offered

12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Octapharma Main Business Overview

12.4.5 Octapharma Latest Developments

12.5 Biotest

12.5.1 Biotest Company Information

12.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Offered

12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Biotest Main Business Overview

12.5.5 Biotest Latest Developments

12.6 Kedrion

12.6.1 Kedrion Company Information

12.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Offered

12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Kedrion Main Business Overview

12.6.5 Kedrion Latest Developments

12.7 Hualan Bio

12.7.1 Hualan Bio Company Information

12.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered

12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Hualan Bio Main Business Overview

12.7.5 Hualan Bio Latest Developments

12.8 CNBG

12.8.1 CNBG Company Information

12.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Offered

12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 CNBG Main Business Overview

12.8.5 CNBG Latest Developments

12.9 Shanghai RAAS

12.9.1 Shanghai RAAS Company Information

12.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered

12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Shanghai RAAS Main Business Overview

12.9.5 Shanghai RAAS Latest Developments

12.10 CBPO

12.10.1 CBPO Company Information

12.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Offered

12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 CBPO Main Business Overview

12.10.5 CBPO Latest Developments

12.11 LFB Group

12.11.1 LFB Group Company Information

12.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Offered

12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 LFB Group Main Business Overview

12.11.5 LFB Group Latest Developments

12.12 BPL

12.12.1 BPL Company Information

12.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Offered

12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 BPL Main Business Overview

12.12.5 BPL Latest Developments

12.13 Sichuan Yuanda Shuyang

12.13.1 Sichuan Yuanda Shuyang Company Information

12.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered

12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Sichuan Yuanda Shuyang Main Business Overview

12.13.5 Sichuan Yuanda Shuyang Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of IVIg Liquid

Table 3. Major Players of IVIg Powder

Table 4. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)

Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & ($ million)

Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)

Table 8. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2016-2021)

Table 9. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)

Table 10. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Table 11. Global Intravenous Immunoglobulin (IVIg) Value by Application (2016-2021)

Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)

Table 13. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2016-2021)

Table 14. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2019-2021) & (K Bottle)

Table 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2019-2021)

Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2019-2021)

Table 18. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution and Sales Area

Table 20. Players Intravenous Immunoglobulin (IVIg) Products Offered

Table 21. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) (K Bottle)

Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)

Table 26. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)

Table 28. Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)

Table 29. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)

Table 30. Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)

Table 32. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)

Table 33. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

Table 34. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)

Table 35. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Table 36. APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)

Table 37. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)

Table 38. APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)

Table 40. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)

Table 41. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

Table 42. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)

Table 43. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Table 44. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)

Table 45. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)

Table 46. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)

Table 48. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)

Table 49. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)

Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)

Table 53. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)

Table 57. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)

Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Intravenous Immunoglobulin (IVIg)

Table 61. Key Application and Potential Industries of Intravenous Immunoglobulin (IVIg)

Table 62. Key Challenges of Intravenous Immunoglobulin (IVIg)

Table 63. Key Trends of Intravenous Immunoglobulin (IVIg)

Table 64. Intravenous Immunoglobulin (IVIg) Distributors List

Table 65. Intravenous Immunoglobulin (IVIg) Customer List

Table 66. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026) & (K Bottle)

Table 67. Global Intravenous Immunoglobulin (IVIg) Consumption Market Forecast by Region

Table 68. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)

Table 71. Americas Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026) & (K Bottle)

Table 73. APAC Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)

Table 75. Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)

Table 77. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026) & (K Bottle)

Table 79. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026) & (K Bottle)

Table 83. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2021-2026)

Table 86. Baxter Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 87. Baxter Intravenous Immunoglobulin (IVIg) Product Offered

Table 88. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 89. Baxter Main Business

Table 90. Baxter Latest Developments

Table 91. Grifols Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 92. Grifols Intravenous Immunoglobulin (IVIg) Product Offered

Table 93. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 94. Grifols Main Business

Table 95. Grifols Latest Developments

Table 96. CSL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 97. CSL Intravenous Immunoglobulin (IVIg) Product Offered

Table 98. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 99. CSL Main Business

Table 100. CSL Latest Developments

Table 101. Octapharma Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 102. Octapharma Intravenous Immunoglobulin (IVIg) Product Offered

Table 103. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 104. Octapharma Main Business

Table 105. Octapharma Latest Developments

Table 106. Biotest Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 107. Biotest Intravenous Immunoglobulin (IVIg) Product Offered

Table 108. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 109. Biotest Main Business

Table 110. Biotest Latest Developments

Table 111. Kedrion Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 112. Kedrion Intravenous Immunoglobulin (IVIg) Product Offered

Table 113. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 114. Kedrion Main Business

Table 115. Kedrion Latest Developments

Table 116. Hualan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 117. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered

Table 118. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 119. Hualan Bio Main Business

Table 120. Hualan Bio Latest Developments

Table 121. CNBG Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 122. CNBG Intravenous Immunoglobulin (IVIg) Product Offered

Table 123. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 124. CNBG Main Business

Table 125. CNBG Latest Developments

Table 126. Shanghai RAAS Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 127. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered

Table 128. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 129. Shanghai RAAS Main Business

Table 130. Shanghai RAAS Latest Developments

Table 131. CBPO Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 132. CBPO Intravenous Immunoglobulin (IVIg) Product Offered

Table 133. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 134. CBPO Main Business

Table 135. CBPO Latest Developments

Table 136. LFB Group Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 137. LFB Group Intravenous Immunoglobulin (IVIg) Product Offered

Table 138. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 139. LFB Group Main Business

Table 140. LFB Group Latest Developments

Table 141. BPL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 142. BPL Intravenous Immunoglobulin (IVIg) Product Offered

Table 143. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 144. BPL Main Business

Table 145. BPL Latest Developments

Table 146. Sichuan Yuanda Shuyang Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors

Table 147. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered

Table 148. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)

Table 149. Sichuan Yuanda Shuyang Main Business

Table 150. Sichuan Yuanda Shuyang Latest Developments

List of Figures

Figure 1. Picture of Intravenous Immunoglobulin (IVIg)

Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2016-2026 (K Bottle)

Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Intravenous Immunoglobulin (IVIg) Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of IVIg Liquid

Figure 10. Product Picture of IVIg Powder

Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020

Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)

Figure 13. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency

Figure 14. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2016-2021) & (K Bottle)

Figure 15. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease

Figure 16. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2016-2021) & (K Bottle)

Figure 17. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection

Figure 18. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2016-2021) & (K Bottle)

Figure 19. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)

Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2020

Figure 21. Intravenous Immunoglobulin (IVIg) Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2020

Figure 23. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2016-2021)

Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2020

Figure 25. Americas Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)

Figure 26. Americas Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)

Figure 27. APAC Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)

Figure 28. APAC Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)

Figure 29. Europe Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)

Figure 30. Europe Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)

Figure 32. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)

Figure 33. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020

Figure 34. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020

Figure 35. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020

Figure 36. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020

Figure 37. United States Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2020

Figure 42. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2020

Figure 43. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020

Figure 44. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020

Figure 45. China Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020

Figure 52. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020

Figure 53. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020

Figure 54. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020

Figure 55. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020

Figure 64. Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample


+1